BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mo C, Sun G, Lu ML, Zhang L, Wang YZ, Sun X, Yang YS. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol 2015; 21(17): 5382-5392 [PMID: 25954113 DOI: 10.3748/wjg.v21.i17.5382]
URL: https://www.wjgnet.com/1007-9327/full/v21/i17/5382.htm
Number Citing Articles
1
Alexandra Demcsák, Tamás Lantos, Emese Réka Bálint, Petra Hartmann, Áron Vincze, Judit Bajor, László Czopf, Hussain Alizadeh, Zoltán Gyöngyi, Katalin Márta, Alexandra Mikó, Zsolt Szakács, Dániel Pécsi, Péter Hegyi, Imre László Szabó. PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-AnalysisFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01550
2
Nina A. Hilkens, Ale Algra, Hans Christoph Diener, Philip M. Bath, László Csiba, Werner Hacke, L. Jaap Kappelle, Peter J. Koudstaal, Didier Leys, Jean-Louis Mas, Ralph L. Sacco, Jacoba P. Greving. Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or StrokeStroke 2021; 52(10): 3258 doi: 10.1161/STROKEAHA.120.031755
3
Ursula Wolf, Martina Wegener. Proton Pump Inhibitor Prescription in Nursing Home Residents: Prevalence, Appropriateness, and Associated Factors—A Secondary Data Analysis from Three German Regions and the Impact of Guideline RecommendationsPharmaceuticals 2024; 17(8): 1082 doi: 10.3390/ph17081082
4
Wen Hu, Jin Tong, Xue Kuang, Weijie Chen, Zengzhang Liu. Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrelMedicine 2018; 97(3): e9638 doi: 10.1097/MD.0000000000009638
5
Ramesh GN, Richard Hunt, Leonid B Lazebnik, Yury C Marakhouski, Mircea Manuc, Khin S Aye, Dmitry S Bordin, Natalia V Bakulina, Baurzhan S Iskakov, Abror A Khamraev, Yurii M Stepanov, Reidwaan Ally, Amit Garg. International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-GEuroasian Journal of Hepato-Gastroenterology 2018; 8(2): 148 doi: 10.5005/jp-journals-10018-1281
6
Lara Aguilera Castro, Carlos Martín de Argila de Prados, Agustín Albillos Martínez. Practical considerations in the management of proton-pump inhibitorsRevista Española de Enfermedades Digestivas 2015;  doi: 10.17235/reed.2015.3812/2015
7
Azita H. Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John W. Eikelboom, Deborah M. Siegal, Manuel Monreal, David Jimenez, Muthiah Vaduganathan, Lana A. Castellucci, Adam Cuker, Geoffrey D. Barnes, Jean M. Connors, Eric A. Secemsky, Benjamin W. Van Tassell, Raffaele De Caterina, Jacob E. Kurlander, Ali Aminian, Gregory Piazza, Samuel Z. Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J. Kirtane, Mitchell S. V. Elkind, Dominick J. Angiolillo, Stavros Konstantinides, Gregory Y. H. Lip, Gregg W. Stone, Mary Cushman, Harlan M. Krumholz, Roxana Mehran, Deepak L. Bhatt, Behnood Bikdeli. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal diseaseNature Reviews Cardiology 2024; 21(8): 574 doi: 10.1038/s41569-024-01003-3
8
Carmelo José Espinosa-Almanza, Hernando Gaitán-Duarte. Enfermedad renal crónica y sangrado entre pacientes bajo profilaxis con heparinas de bajo peso molecularRevista de la Facultad de Medicina 2017; 65(4): 627 doi: 10.15446/revfacmed.v65n4.59769
9
Lorenzo Porta, Francesca Baorda, Alessandra Fusco. Is proton pump inhibitors’ prophylaxis indicated for patients on antiplatelet therapy?Internal and Emergency Medicine 2018; 13(4): 585 doi: 10.1007/s11739-018-1827-9
10
Esra’a Samara, Zaher Nazzal, Shayma Naghnaghia, Rowa’ AL-Ramahi, Muhammad Eid Akkawi. Potentially inappropriate medication uses and associated factors among elderly primary health care clinics attendees: A call to actionPLOS ONE 2023; 18(8): e0290625 doi: 10.1371/journal.pone.0290625
11
Tatyana A. Shamliyan, Maria Middleton, Clarissa Borst. Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other DrugsClinical Therapeutics 2017; 39(2): 404 doi: 10.1016/j.clinthera.2017.01.011
12
Javad Parvizi, Ronald Huang, Camilo Restrepo, Antonia F. Chen, Matthew S. Austin, William J. Hozack, Jess H. Lonner. Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint ArthroplastyJournal of Bone and Joint Surgery 2017; 99(2): 91 doi: 10.2106/JBJS.16.00147
13
Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001Zeitschrift für Gastroenterologie 2023; 61(05): 544 doi: 10.1055/a-1975-0414
14
Masaomi Tatsuzawa, Ryuichi Ogawa, Atsushi Ohkubo, Kazuyo Shimojima, Kunimi Maeda, Hirotoshi Echizen, Akihisa Miyazaki. Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart reviewJournal of Pharmaceutical Health Care and Sciences 2016; 2(1) doi: 10.1186/s40780-016-0068-1
15
Carl J. Lavie, Colin W. Howden, James Scheiman, James Tursi. Upper Gastrointestinal Toxicity Associated With Long-Term Aspirin Therapy: Consequences and PreventionCurrent Problems in Cardiology 2017; 42(5): 146 doi: 10.1016/j.cpcardiol.2017.01.006
16
Zhuoya Li, Zheng Wang, Baile Shen, Chen Chen, Xiaoyun Ding, Haojun Song. Effects of aspirin on the gastrointestinal tract: Pros vs. cons (Review)Oncology Letters 2020; 20(3): 2567 doi: 10.3892/ol.2020.11817
17
O. M. Drapkina, T. V. Vavilova, Yu. A. Karpov, Zh. D. Kobalava, N. V. Lomakin, А. I. Martynov, E. V. Roitman, D. A. Sychev. The resolution of the Expert Council on current issues of the use of acetylsalicylic acid for the purpose of primary prevention of cardiovascular diseases in the light of new scientific data and updated clinical guidelinesCardiovascular Therapy and Prevention 2023; 21(12): 3487 doi: 10.15829/1728-8800-2022-3487
18
James R. Lawrence, Gwendoline J. Baxter, John R. Paterson. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient rootsMedical Hypotheses 2016; 94: 74 doi: 10.1016/j.mehy.2016.07.001
19
Weam El Hajj, Stéphane Nahon, Eddy Fares, Vincent Quentin, Denis Grasset, Jean-Pierre Arpurt, Florence Skinazi, René-Louis Vitte, Laurent Costes, André-Jean Remy, Christophe Locher, Gilles Macaigne, Christophe Agnello, Frédérique Alabert, Morgane Amil, Yves Arondel, Ramuntcho Arotcarena, Jean-Pierre Arpurt, Karim Aziz, Mathieu Baconnier, Sandrine Barge, Georges Barjonet, Julien Baudon, Lucile Bauguion, Marie Bellecoste, Serge Bellon, Alban Benezech, Aliou Berete, Chantal Berger, Jean-Guy Bertolino, Karine Bideau, Gaëlle Billet, Massimo Bocci, Isabelle Borel, Madina Boualit, Dominique Boutroux, Slim Bramli, Pascale Catala, Claire Charpignon, Jonathan Chelly, Marie Colin, Rémi Combes, Laurent Costes, Baya Coulibaly, David Cuen, Gaëlle D’hautefeuille, Hortense Davy, Mercedes DE Lustrac, Stéphanie DE Montigny-Lenhardt, Jean-Bernard Delobel, Anca-Stela Dobrin, Florent Ehrhard, Khaldoun Elriz, Anouk Esch, Roger Faroux, Mathilde Fron, Cécile Garceau, Armand Garioud, Edmond Geagea, Denis Grasset, Loïc Guerbau, Jessica Haque, Florence Harnois, Frédéric Heluwaert, Denis Heresbach, Sofia Herrmann, Clémence Horaist, Mehdi Kaassis, Jean Kerneis, Carelle Koudougou, Ludovic Lagin, Margot Laly, You-Heng Lam, Rachida Leblanc-Boubchir, Antonia Legruyer, Delphine Lemee, Christophe Locher, Dominique Louvel, Henri Lubret, Gilles Macaigne, Vincent Mace, Emmanuel Maillard, Magdalena Meszaros, Mohammed Redha Moussaoui, Stéphane Nahon, Amélie Nobecourt, Etienne Pateu, Thierry Paupard, Arnaud Pauwels, Agnès Pelaquier, Olivier Pennec, Mathilde Petiet, Fabien Pinard, Vanessa Polin, Marc Prieto, Gilles Quartier, Vincent Quentin, André-Jean Remy, Marie-Pierre Ripault, Isabelle Rosa, Thierry Salvati, Matthieu Schnee, Leila Senouci, Florence Skinazi, Nathalie Talbodec, Quentin Thiebault, Ivan Touze, Marie Trompette, Laurent Tsakiris, Hélène Vandamme, Charlotte Vanveuren, Juliette Verlynde, Joseph Vickola, René-Louis Vitte, Faustine Wartel, Oana Zaharia, David Zanditenas, Patrick Zavadil. Prophylactic Proton Pump Inhibitors in Upper Gastrointestinal Bleeding: Impact and Underprescription in a French Multicentric CohortDigestive Diseases and Sciences 2024;  doi: 10.1007/s10620-024-08663-8
20
Luis A. García Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Pareen Vora, Lucía Cea Soriano. Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational StudyJournal of Clinical Medicine 2020; 9(4): 928 doi: 10.3390/jcm9040928
21
Bianca Clerici, Marco Cattaneo. Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative ReviewJournal of Cardiovascular Development and Disease 2023; 10(4): 137 doi: 10.3390/jcdd10040137
22
Anca Negovan, Mihaela Iancu, Valeriu Moldovan, Kinga Sàrkàny, Simona Bataga, Simona Mocan, Ioan Țilea, Claudia Banescu. The contribution of clinical and pathological predisposing factors to severe gastro-duodenal lesions in patients with long-term low-dose aspirin and proton pump inhibitor therapyEuropean Journal of Internal Medicine 2017; 44: 62 doi: 10.1016/j.ejim.2017.05.017
23
Yao-Sheng Shang, Peng-Yu Zhong, Ying Ma, Nan Bai, Ying Niu, Zhi-Lu Wang. Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-AnalysisJournal of Cardiovascular Pharmacology 2022; 80(1): 1 doi: 10.1097/FJC.0000000000001284
24
Michael E. Farkouh. A COGENT Argument for Gastrointestinal Protection With Low-Dose Aspirin ∗Journal of the American College of Cardiology 2016; 67(14): 1672 doi: 10.1016/j.jacc.2016.01.039
25
Dorota Ksiądzyna, Adam Szeląg. The Proton Pump Inhibitors Use and COVID-19 from Prior to Vaccination Perspective: A ReviewDigestive Diseases 2023; 41(3): 513 doi: 10.1159/000527501
26
C. Suárez Ferrer, J.L. Rueda García, M.D. Martín-Arranz. Gastritis y gastropatías (I). Gastritis infecciosas y tóxicasMedicine - Programa de Formación Médica Continuada Acreditado 2024; 14(2): 76 doi: 10.1016/j.med.2024.02.002
27
Mariko Hojo, Takashi Asahara, Akihito Nagahara, Tsutomu Takeda, Kohei Matsumoto, Hiroya Ueyama, Kenshi Matsumoto, Daisuke Asaoka, Takuya Takahashi, Koji Nomoto, Yuichiro Yamashiro, Sumio Watanabe. Gut Microbiota Composition Before and After Use of Proton Pump InhibitorsDigestive Diseases and Sciences 2018; 63(11): 2940 doi: 10.1007/s10620-018-5122-4
28
Ramon Luengo-Fernandez, Linxin Li, Peter M Rothwell. Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitorsInternational Journal of Stroke 2021; 16(6): 719 doi: 10.1177/1747493019879658
29
Hui Hua, Hongying Zhang, Qingbin Kong, Jiao Wang, Yangfu Jiang. Complex roles of the old drug aspirin in cancer chemoprevention and therapyMedicinal Research Reviews 2019; 39(1): 114 doi: 10.1002/med.21514
30
Joachim Mössner. The Indications, Applications, and Risks of Proton Pump InhibitorsDeutsches Ärzteblatt international 2016;  doi: 10.3238/arztebl.2016.0477
31
Alexandru Burlacu, Simonetta Genovesi, David Goldsmith, Patrick Rossignol, Alberto Ortiz, Philip A. Kalra, Jolanta Małyszko, Maciej Banach, Mehmet Kanbay, Adrian Covic. Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisalPharmacological Research 2018; 129: 535 doi: 10.1016/j.phrs.2017.12.004
32
Marouf Mouhammad Alhalabi. Mortality and risk factors associated with peptic ulcer bleeding among adult inpatients of Damascus Hospital, Syria: A cross-sectional studyMedicine 2023; 102(17): e33699 doi: 10.1097/MD.0000000000033699
33
Anna Graipe, Anders Ulvenstam, Anna-Lotta Irevall, Lars Söderström, Thomas Mooe. Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort studyScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01525-7
34
Peter C. Elwood, Janet E. Pickering, Gareth Morgan, Julieta Galante, Alison L. Weightman, Delyth Morris, Marcus Longley, Malcolm Mason, Richard Adams, Sunil Dolwani, John Chia W. K., Angel Lanas, Daotai Nie. Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?PLOS ONE 2018; 13(9): e0203957 doi: 10.1371/journal.pone.0203957
35
Isabel Laucirica, Pilar García Iglesias, Xavier Calvet. Úlcera pépticaMedicina Clínica 2023; 161(6): 260 doi: 10.1016/j.medcli.2023.05.008
36
Jemi Feiona Vergil Andrews, Divya Bharathi Selvaraj, Akshay Kumar, Syed Aasish Roshan, Muthuswamy Anusuyadevi, Mahesh Kandasamy. A Mild Dose of Aspirin Promotes Hippocampal Neurogenesis and Working Memory in Experimental Ageing MiceBrain Sciences 2023; 13(7): 1108 doi: 10.3390/brainsci13071108
37
C. Schulz, S. Nitschmann. Helicobacter-pylori-Eradikation zur Prävention von UlkusblutungenDie Innere Medizin 2023; 64(5): 506 doi: 10.1007/s00108-023-01493-2
38
Weijun Guo, Wenlin Lu, Yujun Xu, Liansheng Wang, Qin Wei, Qingyun Zhao. Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin AdministrationClinical Drug Investigation 2017; 37(2): 187 doi: 10.1007/s40261-016-0474-z
39
Nina A. Hilkens, Linxin Li, Peter M. Rothwell, Ale Algra, Jacoba P. Greving. External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke PatientsStroke 2018; 49(3): 601 doi: 10.1161/STROKEAHA.117.019259
40
Susanna M. Wallerstedt, Johan Fastbom, Johannes Linke, Sigurd Vitols. Long‐term use of proton pump inhibitors and prevalence of disease‐ and drug‐related reasons for gastroprotection—a cross‐sectional population‐based studyPharmacoepidemiology and Drug Safety 2017; 26(1): 9 doi: 10.1002/pds.4135
41
Jing Zhao, Yihong Fan, Wu Ye, Wen Feng, Yue Hu, Lijun Cai, Bin Lu. The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal InjuriesGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/6532876
42
Aitor Lanas-Gimeno, Gonzalo Hijos, Ángel Lanas. Proton pump inhibitors, adverse events and increased risk of mortalityExpert Opinion on Drug Safety 2019; 18(11): 1043 doi: 10.1080/14740338.2019.1664470
43
Cody Magnusson. Antiplatelet cessation to manage bleeding events in elderly peopleThe Lancet 2017; 390(10112): 2547 doi: 10.1016/S0140-6736(17)33086-6
44
Norihito Kanai, Masazumi Ando, Momoko Shimodate, Yoshiko Miyazaki, Toshio Saito. Influence of Hospital Formularies on Outpatient Prescribing Practices: Analysis of the Introduction of a Local Formulary: A Single-Center, 2-Year Follow-Up, Retrospective Cohort Study of a Local Formulary in JapanINQUIRY: The Journal of Health Care Organization, Provision, and Financing 2022; 59 doi: 10.1177/00469580221087876
45
Jaqui Walker. Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuumCardiology Plus 2022; 7(2): 64 doi: 10.1097/CP9.0000000000000017
46
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of viewWorld Journal of Cardiology 2023; 15(8): 375-394 doi: 10.4330/wjc.v15.i8.375
47
Linxin Li, Olivia C Geraghty, Ziyah Mehta, Peter M Rothwell. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort studyThe Lancet 2017; 390(10093): 490 doi: 10.1016/S0140-6736(17)30770-5
48
Xiao-Ying Li, Li Li, Sang-Hoon Na, Francesca Santilli, Zhongwei Shi, Michael Blaha. Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular diseaseAmerican Journal of Preventive Cardiology 2022; 11: 100363 doi: 10.1016/j.ajpc.2022.100363
49
Masato Nakamura, Tomoko Iizuka, Kei Sagawa, Kenji Abe, Shuichi Chikada, Miyuki Arai. Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational studyCardiovascular Intervention and Therapeutics 2018; 33(2): 135 doi: 10.1007/s12928-017-0459-8
50
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, D. S. Zlobina, L. Yu. Koroleva. Gastrointestinal Bleeding in Patients with Coronary Heart Disease: Preventive OptionsKardiologiia 2020; 60(7): 125 doi: 10.18087/cardio.2020.7.n942
51
R. H. Olie, P. E. J. van der Meijden, H. M. H. Spronk, H. ten Cate. Handbook of Experimental Pharmacology 2020;  doi: 10.1007/164_2020_357
52
Kelly E. Lloyd, Robbie Foy, Louise H. Hall, Lucy Ziegler, Sophie M. C. Green, Zainab F. Haider, David G. Taylor, Mairead MacKenzie, Samuel G. Smith. Barriers and facilitators to using aspirin for preventive therapy: a qualitative study exploring the views and experiences of people with Lynch syndrome and healthcare providersHereditary Cancer in Clinical Practice 2022; 20(1) doi: 10.1186/s13053-022-00235-z
53
Keith T. Veltri. YospralaCardiology in Review 2018; 26(1): 50 doi: 10.1097/CRD.0000000000000174
54
Carmelo J. Espinosa Almanza, Hernando G. Gaitan Duarte, Oscar A. Guevara Cruz, Luis F. Sanchez Solanilla, Rocio P. Sanabria Rodriguez. Association between renal dysfunction and the development of bleeding during prophylactic doses of low molecular weight heparins, a nested case-control studyGazzetta Medica Italiana Archivio per le Scienze Mediche 2019; 178(1-2) doi: 10.23736/S0393-3660.17.03704-4
55
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth M Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, Athira Balakrishnan Nair, Paul T. Antony, Alexander C. Ford, Nathorn Chaiyakunapruk. Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trialsBritish Journal of Clinical Pharmacology 2022; 88(4): 1551 doi: 10.1111/bcp.15103
56
Hyun Kuk Kim, Youngkeun Ahn, Kiyuk Chang, Young-Hoon Jeong, Joo-Yong Hahn, Eun Ho Choo, Min Chul Kim, Hyo-Soo Kim, Weon Kim, Myeong-Chan Cho, Yangsoo Jang, Chong Jin Kim, Myung Ho Jeong, Shung Chull Chae. 2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial InfarctionKorean Circulation Journal 2020; 50(10): 845 doi: 10.4070/kcj.2020.0196
57
Lei Fang, Wansi Zhong, Xiaoxian Gong, Zhicai Chen, Yi Chen, Shenqiang Yan, Min Lou. Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort StudyJournal of Clinical Medicine 2022; 11(23): 6881 doi: 10.3390/jcm11236881
58
Isabel Laucirica, Pilar Garcia Iglesias, Xavier Calvet. Peptic ulcerMedicina Clínica (English Edition) 2023; 161(6): 260 doi: 10.1016/j.medcle.2023.05.015
59
Antonio Rodríguez‐Miguel, Luis A. García‐Rodríguez, Miguel Gil, Diana Barreira‐Hernández, Sara Rodríguez‐Martín, Francisco J. de Abajo. Population‐based case‐control study: chemoprotection of colorectal cancer with non‐aspirin nonsteroidal anti‐inflammatory drugs and other drugs for pain controlAlimentary Pharmacology & Therapeutics 2019; 50(3): 295 doi: 10.1111/apt.15333
60
Supinya Dechanont, Arom Jedsadayanmata, Bodin Butthum, Chuenjid Kongkaew. Hospital Admissions Associated With Medication-Related Problems in Thai Older Patients: A Multicenter Prospective Observational StudyJournal of Patient Safety 2021; 17(1): 15 doi: 10.1097/PTS.0000000000000627
61
Hiroyuki Tsujimoto, Yuki Hirata, Yasuhiro Ueda, Naohiko Kinoshita, Hideki Tawa, Yasuyoshi Tanaka, Ryoji Koshiba, Kazuhiro Ota, Yuichi Kojima, Kazuki Kakimoto, Toshihisa Takeuchi, Takako Miyazaki, Shiro Nakamura, Kazuhide Higuchi. Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirinEuropean Journal of Clinical Pharmacology 2021; 77(11): 1639 doi: 10.1007/s00228-021-03167-0
62
Gautam Ray. Incidence and outcome of gastrointestinal bleeding in patients receiving aspirin with or without clopidogrel over 10 years- An observational studyJournal of Family Medicine and Primary Care 2022; 11(12): 7750 doi: 10.4103/jfmpc.jfmpc_1298_22
63
Makiko Iwasawa, Kyoichi Wada, Mitsutaka Takada. Gastrointestinal risk factors and prescribing pattern of antiulcer agents in patients taking low-dose aspirin in JapanInternational Journal of Pharmacy Practice 2018; 26(4): 369 doi: 10.1111/ijpp.12412
64
Alan P Jacobsen, John W McEvoy. Changing place for aspirin in primary prevention of cardiovascular diseaseDrug and Therapeutics Bulletin 2020; 58(1): 3 doi: 10.1136/dtb.2019.000043
65
Wolfgang Fischbach, Jan Bornschein, Jörg C. Hoffmann, Sibylle Koletzko, Alexander Link, Lukas Macke, Peter Malfertheiner, Kerstin Schütte, Dieter-Michael Selgrad, Sebastian Suerbaum, Christian Schulz. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)Zeitschrift für Gastroenterologie 2024; 62(02): 261 doi: 10.1055/a-2181-2225
66
Non-Neoplastic Disorders of the Gastrointestinal Tract2021; : 95 doi: 10.55418/9781933477930-03
67
Guillermo García-Rayado, Carlos Sostres, Angel Lanas. Aspirin and omeprazole for secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcersExpert Review of Clinical Pharmacology 2017; 10(8): 875 doi: 10.1080/17512433.2017.1324782
68
Moritz Schmidbauer, Johannes Wischmann, Konstantinos Dimitriadis, Lars Kellert. Sekundärprophylaxe des ischämischen SchlaganfallsDie Innere Medizin 2023; 64(12): 1171 doi: 10.1007/s00108-023-01615-w
69
Sven Lerch. Akuttherapie des ischämischen SchlaganfallsGeriatrie-Report 2020; 15(1): 40 doi: 10.1007/s42090-019-0003-3
70
Tomoari Kamada, Kiichi Satoh, Toshiyuki Itoh, Masanori Ito, Junichi Iwamoto, Tadayoshi Okimoto, Takeshi Kanno, Mitsushige Sugimoto, Toshimi Chiba, Sachiyo Nomura, Mitsuyo Mieda, Hideyuki Hiraishi, Junji Yoshino, Atsushi Takagi, Sumio Watanabe, Kazuhiko Koike. Evidence-based clinical practice guidelines for peptic ulcer disease 2020Journal of Gastroenterology 2021; 56(4): 303 doi: 10.1007/s00535-021-01769-0
71
Luis A. García Rodríguez, Mar Martín-Pérez, Charles H. Hennekens, Peter M. Rothwell, Angel Lanas, Tobias Eckle. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational StudiesPLOS ONE 2016; 11(8): e0160046 doi: 10.1371/journal.pone.0160046
72
Jennifer S. Davis, Preeti Kanikarla-Marie, Mihai Gagea, Patrick L. Yu, Dexing Fang, Manu Sebastian, Peiying Yang, Ernest Hawk, Roderick Dashwood, Lenard M. Lichtenberger, David Menter, Scott Kopetz. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer developmentBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07311-4